Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer
Year: 2013
Type: conference-abstract
Source: Cancer Research
Authors: AS Clark, P Lal, KS Tan, DF Heitjan, M Feldman, P Zhang, M Gallagher, S Domchek, K Gogineni, S Keefe, KR Fox, P O'Dwyer, A DeMichele
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1973017188